These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9826117)

  • 21. [Gaucher's disease].
    Hatano Y; Miura AB
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):383-5. PubMed ID: 9851168
    [No Abstract]   [Full Text] [Related]  

  • 22. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease.
    McEachern KA; Fung J; Komarnitsky S; Siegel CS; Chuang WL; Hutto E; Shayman JA; Grabowski GA; Aerts JM; Cheng SH; Copeland DP; Marshall J
    Mol Genet Metab; 2007 Jul; 91(3):259-67. PubMed ID: 17509920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Gaucher's disease with OGT 918.
    Mistry PK
    Lancet; 2000 Aug; 356(9230):676-7. PubMed ID: 10968454
    [No Abstract]   [Full Text] [Related]  

  • 24. Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.
    Dahl M; Doyle A; Olsson K; Månsson JE; Marques ARA; Mirzaian M; Aerts JM; Ehinger M; Rothe M; Modlich U; Schambach A; Karlsson S
    Mol Ther; 2015 May; 23(5):835-844. PubMed ID: 25655314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease.
    Schuening F; Longo WL; Atkinson ME; Zaboikin M; Kiem HP; Sanders J; Scott CR; Storb R; Miller AD; Reynolds T; Bensinger W; Rowley S; Gooley T; Darovsky B; Appelbaum F
    Hum Gene Ther; 1997 Nov; 8(17):2143-60. PubMed ID: 9414262
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone-marrow transplantation in severe Gaucher's disease.
    Rappeport JM; Ginns EI
    N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preclinical research of a new therapy for Gaucher's disease with F213I mutation].
    Hou L; Kousaku O
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):381-4. PubMed ID: 14556188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors and stimulators of glucocerebroside metabolism.
    Radin NS
    Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
    [No Abstract]   [Full Text] [Related]  

  • 29. [Novel metabolic pathway of glucosylceramide that involves Klotho-related protein KLrP].
    Hayashi Y; Okino N; Ito M
    Seikagaku; 2010 Jan; 82(1):47-53. PubMed ID: 20169998
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase.
    Abdul-Hammed M; Breiden B; Schwarzmann G; Sandhoff K
    J Lipid Res; 2017 Mar; 58(3):563-577. PubMed ID: 28126847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary excretion of glycolipid in induced or inherited glucosylceramide lipidosis.
    Pentchev PG; Gal AE; Wong R; Morrone S; Neumeyer B; Massey J; Kanter R; Sawitsky A; Brady RO
    Biochim Biophys Acta; 1981 Sep; 665(3):615-8. PubMed ID: 7295755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolism of glucocerebrosides - From 1965 to the present.
    Futerman AH; Platt FM
    Mol Genet Metab; 2017; 120(1-2):22-26. PubMed ID: 27955980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism.
    Akiyama H; Hirabayashi Y
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2507-2514. PubMed ID: 28596107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gaucher disease].
    Ida H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):356-9. PubMed ID: 9645082
    [No Abstract]   [Full Text] [Related]  

  • 35. Gaucher disease: pathological mechanisms and modern management.
    Jmoudiak M; Futerman AH
    Br J Haematol; 2005 Apr; 129(2):178-88. PubMed ID: 15813845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of protein-bound epidermal glucosylceramides in beta-glucocerebrosidase deficient type 2 Gaucher mice.
    Doering T; Proia RL; Sandhoff K
    FEBS Lett; 1999 Mar; 447(2-3):167-70. PubMed ID: 10214939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).
    Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY
    J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucocerebrosidase deficiency--Gaucher's disease].
    Tsuji S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):728-33. PubMed ID: 2908399
    [No Abstract]   [Full Text] [Related]  

  • 39. Gaucher's disease, a review.
    Peters SP; Lee RE; Glew RH
    Medicine (Baltimore); 1977 Sep; 56(5):425-42. PubMed ID: 329054
    [No Abstract]   [Full Text] [Related]  

  • 40. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
    Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
    FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.